Promises and pitfalls of anti-angiogenic therapy in clinical trials

Author： McCarty M.F.   Liu W.   Fan F.   Parikh A.   Reimuth N.   Stoeltzing O.   Ellis L.M.  

Publisher： Elsevier

ISSN： 1471-4914

Source： Trends in Molecular Medicine, Vol.9, Iss.2, 2003-02, pp. : 53-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Angiogenic Cancer Therapy Updates

By  

Current Molecular Medicine, Vol. 9, Iss. 8, 2009-11 ,pp. : 954-966

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Endothelial Progenitor Cells in Cancer as a Novel Biomarker and Anti-Angiogenic Therapy

By  

Current Stem Cell Research & Therapy, Vol. 10, Iss. 2, 2015-03 ,pp. : 181-187

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-angiogenic Therapy and Induction of Blood Vessel Normalization in the Treatment of Ovarian Cancer

By  

Current Angiogenesis, Vol. 3, Iss. 4, 2014-01 ,pp. : 203-214

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Endothelial Progenitor Cells in Cancer as a Novel Biomarker and Anti-Angiogenic Therapy

By  

Current Stem Cell Research & Therapy, Vol. 10, Iss. 2, 2015-01 ,pp. : 181-187

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical trials of antibody therapy

By Glennie M.J.   Johnson P.W.M.  

Immunology Today, Vol. 21, Iss. 8, 2000-08 ,pp. : 403-410

Elsevier

Access to resources Recommend Favorite